Long-term Efficacy and Tolerability of Perospirone for Young Help-seeking People at Clinical High Risk: a Preliminary Open Trial
Author:
Affiliation:
1. Department of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan
2. Department of Social Medicine, Toho University School of Medicine, Tokyo, Japan
Publisher
Korean College of Neuropsychopharmacology
Subject
Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health
Link
http://pdf.medrang.co.kr/CPN2/2013/011/cpn-11-132.pdf
Reference22 articles.
1. Prediction of Psychosis in Youth at High Clinical Risk
2. At Clinical High Risk for Psychosis: Outcome for Nonconverters
3. Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis
4. Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample With Subthreshold Symptoms
5. Effects of Development on Olanzapine-Associated Adverse Events
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient-Reported Outcome Measures in Clinical High Risk for Psychosis: A Systematic Review;Schizophrenia Bulletin Open;2023-01-01
2. Interventions and Transition in Youth at Risk of Psychosis;The Journal of Clinical Psychiatry;2020-05-19
3. Pharmacological intervention for people at risk of psychotic disorder;Risk Factors for Psychosis;2020
4. Attenuated Psychosis Syndrome;Schizophrenia Treatment Outcomes;2020
5. Federated multi-site longitudinal study of at-risk mental state for psychosis in Japan;Schizophrenia Research;2019-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3